Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 81.50
-0.40 (-0.49%)
May 21, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 401.34 million as of May 21, 2026. Its market cap has decreased by -35.73% in one year.
Market Cap
401.34M
Enterprise Value
377.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
81.50
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 401.34M, an increase of 248.88%. That is a compound annual growth rate of 31.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 403.31M | 5.54% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 520.20M |
| Captor Therapeutics Spolka Akcyjna | 499.38M |
| BIOTON | 374.37M |
| Syn2bio | 290.16M |
| Synthaverse | 220.10M |
| Mabion | 127.20M |
| Molecure | 111.26M |
| NanoGroup | 102.31M |